STORMS microbiome reporting checklist. by Katrine Carlsen (5477300)

Subjects:

KIF15 mediates the trafficking of PSD95 along microtubules. by Xiaomei He (795333)

Subjects:

Emotional changes in <i>Kif15</i>^<i>-/-</i> mice from adolescence to adulthood. by Xiaomei He (795333)

Subjects:

ExaF contributes to FA homeostasis by lowering the FA concentration. by Zachary T. Hying (21512605)

KIF15 interacts with PSD95 and affect its localization in neuronal cytoplasm neurons of the PFC. by Xiaomei He (795333)

Subjects:

<i>Kif15</i> deficiency affects the expression of excitatory postsynaptic receptors in PFC and hippocampus. by Xiaomei He (795333)

Subjects:

Characteristics of premenopausal and postmenopausal women. by Siyi Deng (12887198)

Subjects:

Multivariate regression analysis of AIP with depression stratified by menopausal status. by Siyi Deng (12887198)

Subjects:

Flow chart of study participants. by Siyi Deng (12887198)

Subjects:

Association between AIP and depression in total people by Siyi Deng (12887198)

Subjects:

Subgroup analysis of AIP and depression. by Siyi Deng (12887198)

Subjects:

Weekly aerobic exercise volume over time for the DHA and placebo groups combined (n  by Claire M. Douglas (21238238)

Subjects:

Weekly resistance training frequency over time for the DHA and placebo groups combined (n  by Claire M. Douglas (21238238)

Subjects:

Quality of life scores at baseline (week 0) and end of chemotherapy (week 18) in the DHA and placebo groups. by Claire M. Douglas (21238238)

Subjects:

Participant demographic and clinical characteristics. by Claire M. Douglas (21238238)

Subjects:

Quality of life scores at baseline (week 0) and the end of chemotherapy (week 18) in participants that met (≥ 150 minutes/week) or did not meet (< 150 minutes/week) WHO’s aerobic e... by Claire M. Douglas (21238238)

Subjects:

Flow of participants through the DHA WIN RCT. Abbreviations: Docosahexaenoic acid (DHA), Docosahexaenoic acid for Women with Breast Cancer in the Neoadjuvant Setting (DHA WIN), ran... by Claire M. Douglas (21238238)

Subjects:

Quality of life scores at baseline (week 0) and the end of chemotherapy (week 18) in participants that met (≥ 2 times/week) or did not meet (< 2 times/week) WHO’s resistance traini... by Claire M. Douglas (21238238)

Subjects:

The sagittal view of T2-weighted Magnetic Resonance Imaging represented a mild decrease in spinal cord diameter without any other lesions at first admission. by Hossein Pourmontaseri (19329565)

Comparison of serum VEGF-A165 concentrations pre-bevacizumab administration in patients with increased VEGF-A post-bevacizumab administration and those with decreased VEGF-A. by Masashi Okawa (8951294)

Subjects: